Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARAB Trial: Intermittent vs Daily Tamsulosin for LUTS/BPH
NCT07308002Phase 4Not yet recruiting
- Sponsor
- Mansoura University
- Start
- Jan 2026
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tamsulosin in benign prostatic hyperplasia (BPH), lower urinary tract symptoms (LUTS), sponsored by Mansoura University. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
tamsulosin
03
Conditions
benign prostatic hyperplasia (BPH)lower urinary tract symptoms (LUTS)
Beyond the preview
Go deeper on NCT07308002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07308002.